skip to main content
Idioma:
Refinado por: colección: Journals@Ovid Complete eliminar
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Artemether-lumefantrine versus amodiaquine plus sulfadoxine-pyrimethamine for uncomplicated falciparum malaria in Burkina Faso: a randomised non-inferiority trial
Artemether-lumefantrine versus amodiaquine plus sulfadoxine-pyrimethamine for uncomplicated falciparum malaria in Burkina Faso: a randomised non-inferiority trial
Material Type:
Artículo 		Añadir a Mi Portal

Artemether-lumefantrine versus amodiaquine plus sulfadoxine-pyrimethamine for uncomplicated falciparum malaria in Burkina Faso: a randomised non-inferiority trial

Zongo, Issaka, MD ; Dorsey, Grant, MD ; Rouamba, Noel, MD ; Tinto, Halidou, PhD ; Dokomajilar, Christian, BA ; Guiguemde, Robert T, MD ; Rosenthal, Philip J, Prof ; Ouedraogo, Jean Bosco, MD

The Lancet (British edition), 2007-02, Vol.369 (9560), p.491-498 [Revista revisada por pares]

England: Elsevier Ltd

Texto completo disponible

Citas Citado por
2
Home management of malaria with artemether-lumefantrine compared with standard care in urban Ugandan children: a randomised controlled trial
Home management of malaria with artemether-lumefantrine compared with standard care in urban Ugandan children: a randomised controlled trial
Material Type:
Artículo 		Añadir a Mi Portal

Home management of malaria with artemether-lumefantrine compared with standard care in urban Ugandan children: a randomised controlled trial

Staedke, Sarah G, Dr ; Mwebaza, Norah, MBChB ; Kamya, Moses R, Prof ; Clark, Tamara D, MPH ; Dorsey, Grant, MD ; Rosenthal, Philip J, Prof ; Whitty, Christopher JM, Prof

The Lancet (British edition), 2009-05, Vol.373 (9675), p.1623-1631 [Revista revisada por pares]

Kidlington: Elsevier Ltd

Texto completo disponible

Citas Citado por
3
Farnesoid X nuclear receptor ligand obeticholic acid for non-cirrhotic, non-alcoholic steatohepatitis (FLINT): a multicentre, randomised, placebo-controlled trial
Farnesoid X nuclear receptor ligand obeticholic acid for non-cirrhotic, non-alcoholic steatohepatitis (FLINT): a multicentre, randomised, placebo-controlled trial
Material Type:
Artículo 		Añadir a Mi Portal

Farnesoid X nuclear receptor ligand obeticholic acid for non-cirrhotic, non-alcoholic steatohepatitis (FLINT): a multicentre, randomised, placebo-controlled trial

Neuschwander-Tetri, Brent A, Prof ; Loomba, Rohit, MD ; Sanyal, Arun J, Prof ; Lavine, Joel E, Prof ; Van Natta, Mark L, MHS ; Abdelmalek, Manal F, MD ; Chalasani, Naga, Prof ; Dasarathy, Srinivasan, MD ; Diehl, Anna Mae, Prof ; Hameed, Bilal, MD ; Kowdley, Kris V, Prof ; McCullough, Arthur, Prof ; Terrault, Norah, Prof ; Clark, Jeanne M, Prof ; Tonascia, James, Prof ; Brunt, Elizabeth M, Prof ; Kleiner, David E, MD ; Doo, Edward, MD

The Lancet (British edition), 2015-03, Vol.385 (9972), p.956-965 [Revista revisada por pares]

England: Elsevier Ltd

Texto completo disponible

Citas Citado por
4
Co-stimulation modulation with abatacept in patients with recent-onset type 1 diabetes: a randomised, double-blind, placebo-controlled trial
Co-stimulation modulation with abatacept in patients with recent-onset type 1 diabetes: a randomised, double-blind, placebo-controlled trial
Material Type:
Artículo 		Añadir a Mi Portal

Co-stimulation modulation with abatacept in patients with recent-onset type 1 diabetes: a randomised, double-blind, placebo-controlled trial

Orban, Tihamer, MD ; Bundy, Brian, PhD ; Becker, Dorothy J, Prof ; DiMeglio, Linda A, MD ; Gitelman, Stephen E, Prof ; Goland, Robin, Prof ; Gottlieb, Peter A, Prof ; Greenbaum, Carla J, MD ; Marks, Jennifer B, Prof ; Monzavi, Roshanak, MD ; Moran, Antoinette, Prof ; Raskin, Philip, Prof ; Rodriguez, Henry, Prof ; Russell, William E, Prof ; Schatz, Desmond, Prof ; Wherrett, Diane, MD ; Wilson, Darrell M, Prof ; Krischer, Jeffrey P, Prof ; Skyler, Jay S, Dr, Prof

The Lancet (British edition), 2011, Vol.378 (9789), p.412-419 [Revista revisada por pares]

Kidlington: Elsevier Ltd

Texto completo disponible

Citas Citado por
5
Antigen-based therapy with glutamic acid decarboxylase (GAD) vaccine in patients with recent-onset type 1 diabetes: a randomised double-blind trial
Antigen-based therapy with glutamic acid decarboxylase (GAD) vaccine in patients with recent-onset type 1 diabetes: a randomised double-blind trial
Material Type:
Artículo 		Añadir a Mi Portal

Antigen-based therapy with glutamic acid decarboxylase (GAD) vaccine in patients with recent-onset type 1 diabetes: a randomised double-blind trial

Wherrett, Diane K, MD ; Bundy, Brian, PhD ; Becker, Dorothy J, Prof ; DiMeglio, Linda A, MD ; Gitelman, Stephen E, Prof ; Goland, Robin, Prof ; Gottlieb, Peter A, Prof ; Greenbaum, Carla J, MD ; Herold, Kevan C, Prof ; Marks, Jennifer B, Prof ; Monzavi, Roshanak, MD ; Moran, Antoinette, Prof ; Orban, Tihamer, MD ; Palmer, Jerry P, MD ; Raskin, Philip, Prof ; Rodriguez, Henry, Prof ; Schatz, Desmond, Prof ; Wilson, Darrell M, Prof ; Krischer, Jeffrey P, Prof ; Skyler, Jay S, Dr, Prof

The Lancet (British edition), 2011-07, Vol.378 (9788), p.319-327 [Revista revisada por pares]

Kidlington: Elsevier Ltd

Texto completo disponible

Citas Citado por

Personalizar los resultados

  1. Editar

Refine Search Results

Ampliar mis resultados

  1.   

  • Realización: ABCD-USP USP   Logos de Redes Sociales: Freepik

Buscando en bases de datos remotas, por favor espere

  • Buscando por
  • enscope:(USP_VIDEOS),scope:("PRIMO"),scope:(USP_FISICO),scope:(USP_EREVISTAS),scope:(USP),scope:(USP_EBOOKS),scope:(USP_PRODUCAO),primo_central_multiple_fe
  • Mostrar lo que tiene hasta ahora